Article | Published:

Dynein motors transport activated Trks to promote survival of target-dependent neurons

Nature Neuroscience volume 7, pages 596604 (2004) | Download Citation

Subjects

Abstract

Mutations that alter dynein function are associated with neurodegenerative diseases, but it is not known why defects in dynein-dependent transport impair neuronal survival. Here we show that dynein function in axons is selectively required for the survival of neurons that depend on target-derived neurotrophins. Stimulation of axon terminals with neurotrophins causes internalization of neurotrophin receptors (Trks). Using real-time imaging of fluorescently tagged Trks, we show that dynein is required for rapid transport of internalized, activated receptors from axon terminals to remote cell bodies. When dynein-based transport is inhibited, neurotrophin stimulation of axon terminals does not support survival. These studies indicate that defects in dynein-based transport reduce trafficking of activated Trks and thereby obstruct the prosurvival effect of target-derived trophic factors, leading to degeneration of target-dependent neurons.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    & Microtubule-based transport systems in neurons: the roles of kinesins and dyneins. Annu. Rev. Neurosci. 23, 39–71 (2000).

  2. 2.

    et al. Mutant dynactin in motor neuron disease. Nat. Genet. 33, 455–456 (2003).

  3. 3.

    et al. Mutations in dynein link motor neuron degeneration to defects in retrograde transport. Science 300, 808–812 (2003).

  4. 4.

    et al. Disruption of dynein/dynactin inhibits axonal transport in motor neurons causing late-onset progressive degeneration. Neuron 34, 715–727 (2002).

  5. 5.

    Selectivity in neurotrophin signaling: theme and variations. Annu. Rev. Neurosci. 26, 299–330 (2003).

  6. 6.

    et al. A signaling endosome hypothesis to explain NGF actions: potential implications for neurodegeneration. Cold Spring Harb. Symp. Quant. Biol. 61, 389–406 (1996).

  7. 7.

    , , & Binding, internalization, and retrograde transport of 125I-nerve growth factor in cultured rat sympathetic neurons. J. Neurosci. 2, 431–442 (1982).

  8. 8.

    , , & NGF signaling from clathrin-coated vesicles. evidence that signaling endosomes serve as a platform for the ras-MAPK pathway. Neuron 32, 801–814 (2001).

  9. 9.

    et al. Rapid nuclear responses to target-derived neurotrophins require retrograde transport of ligand-receptor complex. J. Neurosci. 19, 7889–7900 (1999).

  10. 10.

    & Quantitative demonstration of the retrograde axonal transport of endogenous nerve growth factor. Neurosci. Lett. 39, 1–4 (1983).

  11. 11.

    & Characterization of an NGF-P-trkA retrograde-signaling complex and age-dependent regulation of TrkA phosphorylation in sympathetic neurons. J. Neurosci. 19, 8207–8218 (1999).

  12. 12.

    et al. NGF signaling in sensory neurons: evidence that early endosomes carry NGF retrograde signals. Neuron 39, 69–84 (2003).

  13. 13.

    & Retrograde support of neuronal survival without retrograde transport of nerve growth factor. Science 295, 1536–1539 (2002).

  14. 14.

    , , & Evidence in support of signaling endosome–based retrograde survival of sympathetic neurons. Neuron 39, 57–68 (2003).

  15. 15.

    Local control of neurite development by nerve growth factor. Proc. Natl. Acad. Sci. USA 74, 4516–4519 (1977).

  16. 16.

    NGF and the local control of nerve terminal growth. J. Neurobiol. 25, 599–611 (1994).

  17. 17.

    , & Characteristics of the retrograde axonal transport system for nerve growth factor in the sympathetic nervous system. Brain Res. 82, 117–128 (1974).

  18. 18.

    , & Comparison between the retrograde axonal transport of nerve growth factor and tetanus toxin in motor, sensory and adrenergic neurons. Brain Res. 99, 1–16 (1975).

  19. 19.

    & Retrograde transport and steady-state distribution of I-125-nerve growth factor in rat sympathetic neurons in compartmented cultures. J. Neurosci. 17, 1282–1290 (1997).

  20. 20.

    et al. Neurotrophins use the Erk5 pathway to mediate a retrograde survival response. Nat. Neurosci. 4, 981–988 (2001).

  21. 21.

    , , , & Cell surface Trk receptors mediate NGF-induced survival while internalized receptors regulate NGF-induced differentiation. J. Neurosci. 20, 5671–5678 (2000).

  22. 22.

    , , & Induction of mutant dynamin specifically blocks endocytic coated vesicle formation. J. Cell. Biol. 127, 915–934 (1994).

  23. 23.

    , , & Dynamin-mediated internalization of caveolae. J. Cell. Biol. 141, 85–99 (1998).

  24. 24.

    , , & Effects of mutant rat dynamin on endocytosis. J. Cell. Biol. 122, 565–578 (1993).

  25. 25.

    , & Dynamin is required for the activation of mitogen-activated protein (MAP) kinase by MAP kinase kinase. J. Biol. Chem. 274, 24575–24578 (1999).

  26. 26.

    et al. Studies on the effects of dansylcadaverine and related compounds on receptor-mediated endocytosis in cultured cells. Diabetes Care 7 (suppl. 1), 35–41 (1984).

  27. 27.

    et al. KIFC3, a microtubule minus end–directed motor for the apical transport of annexin XIIIb–associated Triton-insoluble membranes. J. Cell. Biol. 155, 77–88 (2001).

  28. 28.

    One axon, many kinesins: what's the logic? J. Neurocytol. 29, 799–818 (2000).

  29. 29.

    et al. High resolution imaging demonstrates dynein based vesicular transport of activated Trk receptor. J. Neurobiol. 51, 302–312 (2002).

  30. 30.

    et al. Association of Trk neurotrophin receptors with components of the cytoplasmic dynein motor. J. Neurosci. 21, RC125 (2001).

  31. 31.

    , , & Molecular characterization of the 50-kD subunit of dynactin reveals function for the complex in chromosome alignment and spindle organization during mitosis. J. Cell Biol. 132, 617–633 (1996).

  32. 32.

    et al. ER-to-Golgi transport visualized in living cells. Nature 389, 81–85 (1997).

  33. 33.

    , , & Overexpression of the dynamitin (p50) subunit of the dynactin complex disrupts dynein-dependent maintenance of membrane organelle distribution. J. Cell Biol. 139, 469–484 (1997).

  34. 34.

    , , & An NGF-Trka–mediated retrograde signal to transcription factor CREB in sympathetic neurons. Science 277, 1097–1100 (1997).

  35. 35.

    & Rapid retrograde tyrosine phosphorylation of TrkA and other proteins in rat sympathetic neurons in compartmented cultures. J. Cell. Biol. 138, 411–421 (1997).

  36. 36.

    & Retrograde neurotrophin signaling: Trk-ing along the axon. Curr. Opin. Neurobiol. 12, 268–274 (2002).

  37. 37.

    et al. Small molecule inhibitor of mitotic spindle bipolarity identified in a phenotype-based screen. Science 286, 971–974 (1999).

  38. 38.

    et al. Expression of the mitotic motor protein Eg5 in postmitotic neurons: implications for neuronal development. J. Neurosci. 18, 7822–7835 (1998).

  39. 39.

    , , & Quantitative imaging of lateral ErbB1 receptor signal propagation in the plasma membrane. Science 290, 1567–1570 (2000).

  40. 40.

    et al. Overexpression of the Trk tyrosine kinase rapidly accelerates nerve growth factor–induced differentiation. Neuron 9, 883–896 (1992).

  41. 41.

    & Activation of Trk neurotrophin receptors in the absence of neurotrophins. Proc. Natl. Acad. Sci. USA 98, 3555–3560 (2001).

  42. 42.

    , , & Alternative intracellular routing of ErbB receptors may determine signaling potency. J. Biol. Chem. 273, 13819–13827 (1998).

  43. 43.

    et al. The gene encoding alsin, a protein with three guanine-nucleotide exchange factor domains, is mutated in a form of recessive amyotrophic lateral sclerosis. Nat. Genet. 29, 160–165 (2001).

  44. 44.

    et al. Mutant β-spectrin 4 causes auditory and motor neuropathies in quivering mice. Nat. Genet. 29, 61–65 (2001).

  45. 45.

    & Severe peripheral sensory neuron loss and modest motor neuron reduction in mice with combined deficiency of brain-derived neurotrophic factor, neurotrophin 3 and neurotrophin 4/5. Dev. Dyn. 218, 94–101 (2000).

  46. 46.

    et al. GDNF: a potent survival factor for motoneurons present in peripheral nerve and muscle. Science 266, 1062–1064 (1994).

  47. 47.

    et al. Mice lacking the CNTF receptor, unlike mice lacking CNTF, exhibit profound motor neuron deficits at birth. Cell 83, 313–322 (1995).

  48. 48.

    , & Essential function of LIF receptor in motor neurons. Nature 378, 724–727 (1995).

  49. 49.

    et al. Differential utilization of Trk autophosphorylation sites. J. Biol. Chem. 271, 20175–20181 (1996).

  50. 50.

    et al. A simplified system for generating recombinant adenovirus. Proc. Natl. Acad. Sci. USA 95, 2509–2514 (1998).

Download references

Acknowledgements

We thank R. Vallee, M. Lin and P. Silver for plasmids and antibodies; and M. Greenberg, A. Hans, C. Stiles, J. Trinidad, L.-H. Tsai, F. Watson and R. Witt for discussions. This work was supported by grants from the NIH (NS35148 and NS49381), a Quan fellowship (to H.M.H.) and the Claudia Adams Barr Investigator Award (to R.A.S.).

Author information

Affiliations

  1. Department of Neurobiology, Harvard Medical School and Department of Pediatric Oncology, Dana-Farber Cancer Institute, 44 Binney Street, Boston, Massachusetts 02115, USA.

    • Heather M Heerssen
    • , Maria F Pazyra
    •  & Rosalind A Segal

Authors

  1. Search for Heather M Heerssen in:

  2. Search for Maria F Pazyra in:

  3. Search for Rosalind A Segal in:

Competing interests

The authors declare no competing financial interests.

Corresponding author

Correspondence to Rosalind A Segal.

Supplementary information

Videos

  1. 1.

    Supplementary Video 1

    BDNF induces movement of TrkB-GFP positive puncta. TrkB-GFP expressing neurons were stimulated with BDNF and visualized every two minutes. Many GFP-positive puncta move rapidly toward the cell body following BDNF stimulation.

  2. 2.

    Supplementary Video 2

    Vehicle control stimulation of TrkB-GFP expressing neurons induces little movement of GFP-positive puncta. TrkB-GFP expressing neurons were control stimulated and visualized every two minutes. Little movement of GFP-positive puncta is observed.

PDF files

  1. 1.

    Supplementary Fig. 1

    Kinesin inhibitor does not affect retrograde transport or phosphorylation of Trk. (a) DRG neurons were treated with the kinesin inhibitor monastrol or vehicle control (DMSO). Fluorescent WGA was added to cell bodies or distal axons for 12 hours. Monastrol inhibits anterograde, but not retrograde, transport of WGA. (b) TrkB-GFP expressing DRG neurons were treated with monastrol or vehicle, then used for the FRAP transport assay. Monastrol has no effect on BDNF-induced retrograde transport of TrkB, although the vehicle (DMSO) slightly decreases transport (compare with Fig. 2b). (c) DRG neurons were treated with monastrol or vehicle, stimulated with neurotrophin at distal axons for 20 min, then fixed and immunostained for phospho-Trk. In control-treated cultures, neurotrophin stimulation caused a 1.86 ± 0.10 fold increase in axon fluorescence, and a 1.19 ± 0.03 fold increase in cell body fluorescence. In monastrol-treated cultures, neurotrophin stimulation caused a 1.90 ± 0.06 fold increase in axon fluorescence, and a 1.29 ± 0.06 fold increase in cell body fluorescence. P < 0.005 in all conditions.

About this article

Publication history

Received

Accepted

Published

DOI

https://doi.org/10.1038/nn1242

Further reading